Back to search
MMR-D/MSI-H Colorectal Cancers
Clinical trial pipeline · Data from ClinicalTrials.gov
See which MMR-D/MSI-H Colorectal Cancers trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which MMR-D/MSI-H Colorectal Cancers trials you may qualify forThe investigators hypothesize that atezolizumab will improve the prognosis of patients with stage III dMMR CRC ineligible for or refusing oxaliplatin-based adju…
The second line of therapy for patients with MSI-H CRC who experience disease progression on anti-PD1 based therapies is not well defined and there is an unmet…